酸化诱导的奇米拉重新连接致癌酶以触发亡
Manuel L Merz1, Veronika M Shoba1, Rajaiah Pergu1,2,3
1Chemical Biology and Therapeutics Science Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
bioRxiv : the preprint server for biology
|July 15, 2025
概括
研究人员开发了一种新型的酸化诱导化学小分子 (PHICS),用于控制像BCR-ABL.L.这样的过度活跃酶. 这种事件驱动的方法提供了一种新的抗癌策略,克服了对传统药物的耐药性.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 过度活跃的酶与许多疾病有关.
- 目前的药物 (占用驱动的抑制剂) 面临着诸如静态测量要求和耐药性等挑战.
- 需要新的治疗方式来向酶过活性的治疗.
研究的目的:
- 引入一种名为酸化诱导化学小分子 (PHICS) 的新类药物.
- 研究PHICS在抑制瘤性激酶BCR-ABL中的机制.
- 评估PHICS对抗抗药性突变和其他瘤性融合的疗效.
主要方法:
- 酸化诱导化学小分子 (PHICS) 的设计和合成.
- 使用分子动力学模拟来阐明抑制机制.
- 在体外测试PHICS对BCR-ABL依赖的癌细胞和耐药性突变.
主要成果:
- 通过诱导其活性部位残留物的酸化,PHICS有效地抑制BCR-ABL.
- 这种酸化事件触发了静电重排,导致酶抑制.
- 菲克斯证明了对各种BCR-ABL融合和抗性突变的有效性,具有直角抗性机制.
- 事件驱动的方法显示,选择性亡诱导在癌细胞在substoichiometric度.
结论:
- 菲克斯代表了一种新的"事件驱动"治疗方式,用于控制过度活跃的酶.
- 这种方法为传统的"占用驱动"药物提供了替代品,克服了耐药性.
- 这些发现为开发电场和事件驱动的疗法奠定了基础,这些疗法具有直角电阻配置文件.
相关概念视频
Amplifying Signals via Enzymatic Cascade
8.9K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.9K
Interactions Between Signaling Pathways
6.5K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.5K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
MAPK Signaling Cascades
6.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.1K
The Extrinsic Apoptotic Pathway
6.6K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.6K


